Publication overview
This update includes 24 PubMed publications with abstracts from the monitoring window 2026-09-01 to 2026-09-15. The most common themes are comorbiditiesComorbidity: An additional condition existing alongside the primary disease. Acne Inversa is frequently associated with comorbidities including metabolic syndrome, inflammatory bowel disease, spondyloarthritis, and depression., biologicsBiologic: A class of medications derived from living cells that target specific components of the inflammatory process. For Acne Inversa, biologics such as adalimumab and secukinumab are used when other treatments are insufficient., wound care, pain, jak inhibitor.
- Compared with the previous update: not automatically assessed.
- No guideline/NEJM/Lancet-style high-impact matches with abstracts in this window.
- This is a research overview, not a guideline update or medical recommendation.
Top highlights
The most useful signal this round is not a single treatment instruction. It is what researchers are looking at more closely: wound healing after procedures, possible new anti-inflammatory approaches, care quality, and comorbidities.
- Case report of three cases and literature review: is follicular occlusionFollicular Occlusion: The blockage of hair follicles is considered a key starting point in the development of Acne Inversa. When a follicle becomes obstructed, inflammation can spread deep into tissue, leading to nodules, abscesses, and sinus tracts. triad with peripheral/axial spondyloarthritisSpondyloarthritis: A family of inflammatory joint and spine conditions (including ankylosing spondylitis, psoriatic arthritis) that overlap with Acne Inversa. If you have HS and unexplained inflammatory back pain (morning stiffness lasting more than 30 minutes, better with movement), an assessment is worthwhile. involvement an analog of SAPHO syndrome?: The abstract describes a new publication. In practical terms, it focuses on this question or finding: SAPHO syndrome is a rare chronic rheumatic disease characterized by five typical manifestations: synovitis, acne, pustulosis, hyperostosis, and osteitis. The follicular occlusion triad (FOT) comprises hidradenitis sup… What makes it notable here is that it approaches HS through pain, comorbidities, biologics. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42707673)
- Case Report: Achilles enthesitis as the presenting clue to occult sacroiliitis in hidradenitis suppurativa.: The abstract describes a new publication. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa is increasingly recognized as a systemic inflammatory disease with an established overlap with spondyloarthritis. Axial spondyloarthritis is usually suspected when patients report inflammatory… What makes it notable here is that it approaches HS through pain, comorbidities, biologics. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42688744)
- Psoriasiform Dermatitis Following JAK Inhibitor Therapy for Hidradenitis Suppurativa and Crohn’s Disease.: The abstract describes a new publication. In practical terms, it focuses on this question or finding: UpadacitinibUpadacitinib: An oral JAK1 inhibitor already approved for rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, and Crohn's disease. Studied off-label and in trials for Acne Inversa. Brand name: Rinvoq®., a selective JAK1 inhibitor approved for hidradenitis suppurativa (HS) and Crohn’s disease (CD), has been implicated in paradoxical inflammatory reactions; however, upadacitinib-induced psoriasiform derma… What makes it notable here is that it approaches HS through jak inhibitor, comorbidities, biologics. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42699819)
- Recent advances in hidradenitis suppurativa therapeutics: a focus on existing and future medical therapeutics.: The abstract describes a new publication. In practical terms, it focuses on this question or finding: HS is an inflammatory skin condition that causes abscessesAbscess: An inflamed cavity or swelling containing pus or fluid. In hidradenitis suppurativa, abscesses can form as part of the inflammatory disease process and do not automatically mean that a bacterial infection is present. Secondary bacterial infection can occur and may require separate medical assessment. In Acne Inversa, abscesses occur mainly in the armpits, groin, and other skin folds., nodulesNodule: A firm, palpable lump deep in tissue. Nodules can be painful and may progress to abscesses. They are among the typical early signs of Acne Inversa., and tunnelsSinus Tract: A tunnel-like channel under the skin that forms between abscesses or nodules. Sinus tracts indicate more advanced disease and can chronically drain fluid. They are associated with Hurley Stages II and III. in intertriginous areas. Treatment consists of multimodal therapy such as topical and systemic antibiotics, washes and ointments, hormon… What makes it notable here is that it approaches HS through surgery, jak inhibitor, biologics. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42700395)
- Surgical Management of Hidradenitis Suppurativa Using Staged Carbon Dioxide Laser Marsupialization.: The abstract describes a new publication. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a chronic disease marked by symptoms of pain, drainage, and odor. Persistent abscesses, nodules, and scarred tunnels can be resistant to pharmacologic management, with chronic lesions… What makes it notable here is that it approaches HS through wound care, surgery, pain. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. (PMID 42739657)
Featured publication
The featured paper is Case report of three cases and literature review: is follicular occlusion triad with peripheral/axial spondyloarthritis involvement an analog of SAPHO syndrome? in Frontiers in medicine (PMID 42707673). The abstract mainly says this: SAPHO syndrome is a rare chronic rheumatic disease characterized by five typical manifestations: synovitis, acne, pustulosis, hyperostosis, and osteitis. The follicular occlusion triad (FOT) comprises hidradenitis sup…
Why it stands out: it connects to the priority themes pain, comorbidities, biologics and shows what HS researchers are trying to clarify right now. For readers, it matters because it gives one concrete example of how the field is framing a practical question or possible mechanism. The main limitation is that From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full.
What this may mean for patients (carefully, no advice)
If you live with HS, research updates can help you make sense of what’s being studied — for example which outcomes (pain, quality of life) researchers measure, or which comorbidities are increasingly part of the conversation.
But even when a study sounds promising, it usually does not tell you what is right for you personally. Consider using new findings as questions for your next appointment (e.g., “What are realistic goals for me?” or “Which related conditions should we keep an eye on?”), not as instructions.
What we don’t know / limitations
- This update includes only PubMed items with an abstract (without an abstract, safe summarization is limited).
- Studies vary widely (design, populations, outcome measures).
- This update provides no treatment advice and cannot assess individual risk.
Important: decisions belong in clinician conversations
This article is an editorial overview and is not medically reviewed. If something here worries or interests you, use it as a conversation starter for your next appointment. Decisions should always be made with qualified healthcare professionals.
FAQ
Why are there only a few new publications here?
This format is deliberately strict: it includes only new PubMed items from the monitoring window that have an abstract and were not already covered in earlier posts.
Does a new paper mean my treatment should change?
No. A single publication can be useful to know about, but it is usually not enough to guide decisions for one specific person.
Why emphasize limitations so much?
Because abstracts show only part of the picture. Study design, patient population, endpoints, and follow-up all matter before results can be interpreted responsibly.
Sources & original papers
Each point below maps to an original source (PubMed link, plus DOI/PMCID when available).
Terms explained in this article
Quick definitions of the key medical terms. Select any term for its full glossary entry.
- Comorbidity
- An additional condition existing alongside the primary disease. Acne Inversa is frequently associated with comorbidities including metabolic syndrome, inflammatory bowel disease, spondyloarthritis, and depression.
- Biologic
- A class of medications derived from living cells that target specific components of the inflammatory process. For Acne Inversa, biologics such as adalimumab and secukinumab are used when other treatments are insufficient.
- Follicular Occlusion
- The blockage of hair follicles is considered a key starting point in the development of Acne Inversa. When a follicle becomes obstructed, inflammation can spread deep into tissue, leading to nodules, abscesses, and sinus tracts.
- Spondyloarthritis
- A family of inflammatory joint and spine conditions (including ankylosing spondylitis, psoriatic arthritis) that overlap with Acne Inversa. If you have HS and unexplained inflammatory back pain (morning stiffness lasting more than 30 minutes, better with movement), an assessment is worthwhile.
- Upadacitinib
- An oral JAK1 inhibitor already approved for rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, and Crohn's disease. Studied off-label and in trials for Acne Inversa. Brand name: Rinvoq®.
- Abscess
- An inflamed cavity or swelling containing pus or fluid. In hidradenitis suppurativa, abscesses can form as part of the inflammatory disease process and do not automatically mean that a bacterial infection is present. Secondary bacterial infection can occur and may require separate medical assessment. In Acne Inversa, abscesses occur mainly in the armpits, groin, and other skin folds.
- Nodule
- A firm, palpable lump deep in tissue. Nodules can be painful and may progress to abscesses. They are among the typical early signs of Acne Inversa.
- Sinus Tract
- A tunnel-like channel under the skin that forms between abscesses or nodules. Sinus tracts indicate more advanced disease and can chronically drain fluid. They are associated with Hurley Stages II and III.
References
- Disease progression in hidradenitis suppurativa: A multidimensional framework. Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 — PMID 42732549 · DOI 10.1111/jdv.70717
- Lesional hair lipidomic signatures reveal ARA-LTB4 pathway activation and NETs formation in hidradenitis suppurativa. The Journal of investigative dermatology, 2026 — PMID 42731694 · DOI 10.1016/j.jid.2026.09.025
- When anti-tumor necrosis factor-α backfires: paradoxical psoriasis and psoriatic arthritis in a patient with hidradenitis suppurativa. Dermatology reports, 2026 — PMID 42734171 · DOI 10.4081/dr.2026.10808
- The Expanding Role of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Agonists in Dermatology: From Immunometabolism to Clinical Practice. Dermatology and therapy, 2026 — PMID 42728528 · DOI 10.1007/s13555-026-01916-6
- Where the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities. Clinics in dermatology, 2026 — PMID 42727867 · DOI 10.1016/j.clindermatol.2026.09.003
- Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Patients with Hidradenitis Suppurativa. Dermatology and therapy, 2026 — PMID 42722939 · DOI 10.1007/s13555-026-01913-9
- Inflammatory Bowel Disease and Interleukin-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis. JAMA dermatology, 2026 — PMID 42714902 · DOI 10.1001/jamadermatol.2026.3373 · PMCID PMC13559723
- Associations of Active and Passive Smoke Exposure and Hidradenitis Suppurativa in the Pediatric Population: A Case-Control Study. Pediatric dermatology, 2026 — PMID 42713636 · DOI 10.1111/pde.70101
- Recent advances in hidradenitis suppurativa therapeutics: a focus on existing and future medical therapeutics. Expert opinion on emerging drugs, 2026 — PMID 42700395 · DOI 10.1080/14728214.2026.2731005
- GLP-1 Receptor Agonists in Dermatology: Ethical Considerations. Clinics in dermatology, 2026 — PMID 42710719 · DOI 10.1016/j.clindermatol.2026.08.016
- Resorcinol in Dermatology: Reassessing a Legacy Topical Therapy for Contemporary Clinical Use. Dermatology (Basel, Switzerland), 2026 — PMID 42709654 · DOI 10.1159/drm/ackag017
- Trio-based whole-exome sequencing identifies convergent epithelial junction-related pathways in syndromic hidradenitis suppurativa. Dermatology (Basel, Switzerland), 2026 — PMID 42709635 · DOI 10.1159/drm/ackag016
- Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Journal of Crohn's & colitis, 2026 — PMID 42700386 · DOI 10.1093/ecco-jcc/jjag129
- Oral Zinc Supplementation in Acne Vulgaris and Hidradenitis Suppurativa: An Updated Comprehensive Review. Nutrients, 2026 — PMID 42739037 · DOI 10.3390/nu18172865
- Future Integration of Biomarkers for Inflammatory Skin Diseases Into Daily Practice: A Survey Among a Multifaceted Group of Patients and Dermatological Care Providers. Experimental dermatology, 2026 — PMID 42716537 · DOI 10.1111/exd.70352 · PMCID PMC13557849
- Nicastrin Regulates Cutaneous Squamous Cell Carcinoma Progression Through the MAPK/ERK Signalling. Experimental dermatology, 2026 — PMID 42712002 · DOI 10.1111/exd.70350 · PMCID PMC13554823
- LRRC15+ Myofibroblasts as a Stromal State Linking Repair, Fibrosis, and Scarring. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2026 — PMID 42684020 · DOI 10.1111/wrr.70206 · PMCID PMC13536930
- Use of Oxygen-Enriched Oil Dressings in Wound Management: A Scoping Review. Journal of clinical medicine, 2026 — PMID 42739779 · DOI 10.3390/jcm15176770
- Surgical Management of Hidradenitis Suppurativa Using Staged Carbon Dioxide Laser Marsupialization. Journal of clinical medicine, 2026 — PMID 42739657 · DOI 10.3390/jcm15176653
- Correction: Reorganization and functional divergence of the CD4+ memory T cell compartment in hidradenitis suppurativa. Frontiers in immunology, 2026 — PMID 42708026 · DOI 10.3389/fimmu.2026.1940036 · PMCID PMC13548980
- Case report of three cases and literature review: is follicular occlusion triad with peripheral/axial spondyloarthritis involvement an analog of SAPHO syndrome? Frontiers in medicine, 2026 — PMID 42707673 · DOI 10.3389/fmed.2026.1876061 · PMCID PMC13547931
- Case Report: Achilles enthesitis as the presenting clue to occult sacroiliitis in hidradenitis suppurativa. Frontiers in medicine, 2026 — PMID 42688744 · DOI 10.3389/fmed.2026.1932298 · PMCID PMC13535286
- Psoriasiform Dermatitis Following JAK Inhibitor Therapy for Hidradenitis Suppurativa and Crohn's Disease. Cureus, 2026 — PMID 42699819 · DOI 10.7759/cureus.114015 · PMCID PMC13544603
- Cross-Sectional Analysis of Biologic Use in the Treatment of Veterans With Hidradenitis Suppurativa. Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2026 — PMID 42713230 · DOI 10.12788/fp.0667 · PMCID PMC13552704